Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
Prices of ASX stocks are not being updated. The latest FPH price on Alpha Spread is from Oct 15, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
|
NZ |
|
G
|
Goldstorm Metals Corp
F:B2U
|
CA |
Intrinsic Value
The intrinsic value of 
Fisher & Paykel Healthcare Corporation Ltd (FPH) under the Base Case is 30.46 AUD per share.
Compared with the last price of 39.05 AUD on Oct 15, the stock appears
Overvalued by 22% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Fisher & Paykel Healthcare Does
Fisher & Paykel Healthcare makes medical devices that help patients breathe more comfortably. Its main products include hospital systems for breathing support, heated humidification equipment, and sleep apnea therapy devices for home use. The company also supplies masks, tubing, and other disposable parts that are used with these systems.
- Headquarters
- New Zealand NZ
- Employees
- 7 506
- IPO date
- Nov 13, 2001
Fisher & Paykel Healthcare has a narrow economic moat
Hospitals using F&P systems also buy associated disposable supplies, and changing systems can mean replacing equipment and retraining staff. Patents protect some product designs, though established rivals such as ResMed and Philips in sleep and breathing care, and Vapotherm in high-flow therapy, offer alternatives.
Read the full moat analysis
Earnings Waterfall
Fisher & Paykel Healthcare Corporation Ltd
The intrinsic value for Fisher & Paykel Healthcare Corporation Ltd (FPH) under the Base Case is 30.46 AUD.
Compared with the last price of 39.05 AUD on Oct 15, the stock appears Overvalued by 22% .